Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Bios Clinical Opportunity Fund, LP — ACTUATE CORP insider: 3 transactions · InsiderLens

Home / Insiders / Bios Clinical Opportunity Fund, LP

Bios Clinical Opportunity Fund, LP

10% owner at IN8BIO, INC. · on record since Dec 15, 2023
Director at COGNITION THERAPEUTICS INC · on record since Nov 13, 2023
10% owner at COGNITION THERAPEUTICS INC · on record since Nov 13, 2023
Director at ACTUATE CORP · on record since Aug 20, 2024
10% owner at ACTUATE CORP · on record since Aug 20, 2024

Insider trading activity of Bios Clinical Opportunity Fund, LP

Transactions on record: 3; since Aug 20, 2024

Open-market buys: 0

Open-market sells: 3; $200K

Companies traded: 1; last filing Aug 20, 2024

Figures computed from official regulatory filings — methodology.

Companies where Bios Clinical Opportunity Fund, LP has traded

ACTUATE CORP3 tx · $200K · Aug 20, 2024

Track record of Bios Clinical Opportunity Fund, LP

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Bios Clinical Opportunity Fund, LP

Co-insiders of Bios Clinical Opportunity Fund, LP

BIOS Advisors GP, LLCACTUATE CORP +2
BIOS Capital Management, LPACTUATE CORP +2
Bios Equity COF, LPACTUATE CORP +2
BIOS Equity Partners III, LPACTUATE CORP +2
Bios Equity Partners II, LPACTUATE CORP +2
Bios Equity Partners, LPACTUATE CORP +2
BIOS Fund III, LPACTUATE CORP +2

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BIOS Fund III NT, LPACTUATE CORP +2

BIOS Fund III QP, LPACTUATE CORP +2

BIOS Fund II, LPACTUATE CORP +2

BIOS Fund II NT, LPACTUATE CORP +2

BIOS Fund II QP, LPACTUATE CORP +2

BP Directors, LPACTUATE CORP +2

Cavu Advisors, LLCACTUATE CORP +2

Cavu Management, LPACTUATE CORP +2

Fletcher Aaron G.L.ACTUATE CORP +2

Kreis Leslie W.ACTUATE CORP +2

BIOS Fund I, LPACTUATE CORP +1

BIOS Fund I QP, LPACTUATE CORP +1

AKIHA N NOBBYACTUATE CORP

Beelen MelissaIN8BIO, INC.

BEITZEL GEORGE BACTUATE CORP

Bios 2024 Co-Invest, LPACTUATE CORP

Bios Actuate Co-Invest III, LPACTUATE CORP

BIOS Actuate Co-Invest II, LPACTUATE CORP

BIOS Actuate Co-Invest I, LPACTUATE CORP

BIOS Incysus Co-Invest I, LPIN8BIO, INC.

BIOS Memory SPV II, LPCOGNITION THERAPEUTICS INC

BIOS Memory SPV I, LPCOGNITION THERAPEUTICS INC

Boudraa DylanACTUATE CORP

Brandt Peter C.IN8BIO, INC.

Breedlove Mark H.COGNITION THERAPEUTICS INC

Caggiano AnthonyCOGNITION THERAPEUTICS INC

CITTADINI PETER IACTUATE CORP

COGGINS MARKACTUATE CORP

Doyle John BrendanCOGNITION THERAPEUTICS INC

Drifka Amy LACTUATE CORP

Einhorn Andrew J.COGNITION THERAPEUTICS INC

Epperly CorinneIN8BIO, INC.

FAIRBAIRN EMILYIN8BIO, INC.

Fluin StephenACTUATE CORP

GARVEY WILLIAM PACTUATE CORP

GAUDREAU DANIEL AACTUATE CORP

Golden Seeds Cognition Therapeutics LLCCOGNITION THERAPEUTICS INC

Goswami TrishnaIN8BIO, INC.

Graff Jeremy R.IN8BIO, INC.

Greenwood LubaIN8BIO, INC.

Ho William Tai-WeiIN8BIO, INC.

Huber Martin H. Jr.ACTUATE CORP

Kairos-Actuate SPV, L.P.ACTUATE CORP

Company	Filed	Type	Qty	Price	Value · USD	Src
ACTUATE CORP	Aug 20, 2024	Sell	-5,314	8.00 USD	$42.5K	SEC
ACTUATE CORP	Aug 20, 2024	Sell	-17,361	8.00 USD	$138.9K	SEC
ACTUATE CORP	Aug 20, 2024	Sell	-2,324	8.00 USD	$18.6K	SEC